The US pharmaceutical supply chain must be remodeled to address long-standing conflicts and achieve a delivery model marked by transparency, affordability, and access to care, according to an expert...
High-dose buprenorphine induction was safe and well-tolerated in patients with untreated opioid use disorder, according to a JAMA Network Open study.
Researchers gathered data from electronic...
BioNTech recently entered into an agreement with Kite, a Gilead subsidiary, to acquire its solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility to...
Eli Lilly and Company recently entered into a pharma acquisition deal with biotechnology company, Protomer Technologies, to advance treatment for type 1 diabetes (TD1).
Protomer...
Biogen and InnoCare Pharma Limited recently entered into a license and collaboration agreement for orelabrutinib, a potential multiple sclerosis (MS) treatment.
Orelabrutinib is a small molecule...
FDA recently granted emergency use authorization to Ortho Clinical Diagnostics’ COVID-19 antibody test for use as an aid in identifying individuals with adaptive immune responses to the...
Moderna recently announced that the first patient has been dosed in the Phase 1/2 study of its quadrivalent seasonal flu mRNA vaccine candidate.
mRNA-1010 is Moderna’s first seasonal flu vaccine...
FDA has called for a government investigation into the approval of Biogen’s Alzheimer’s drug, Aduhelm, according to multiple news sources.
Experts recently discovered an unreported...
Thermo Fisher Scientific and UC Davis recently launched The Center of Excellence in Clinical Metabolomics to support the rapid scale-up of large cohort studies and clinical research.
The Center of...
FDA recently reversed its broad approval for Biogen’s Alzheimer’s drug, Aduhelm, after being approved just last month, according to multiple news outlets.
The agency now recommends...
Novo Nordisk recently announced that a 2.0-milligram dose of Ozempic elicited a “statistically significant and superior” reduction in HbA1C compared to Ozempic 1.0 milligram in...
Walmart recently announced the first-ever private brand analog insulin to revolutionize diabetes care management and offer customers significant price savings without compromising overall...
FDA recently approved Boehringer Ingelheim Pharmaceuticals Pradaxa, the first oral blood thinning medication for children three months to less than 12 years old with venous thromboembolism.
Pradaxa...
Gilead recently announced that its COVID-19 treatment, remdesivir, lowered the risk for mortality compared with matched controls in patients hospitalized with the virus.
The three real-world data...
Thermo Fisher Scientific recently launched the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve surveillance and identification of new and known COVID-19 variants from samples with lower viral...
US Senators Michael Bennet and Todd Young, and Representatives Mike Doyle and Drew Ferguson recently reintroduced the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act to...
Regeneron recently announced that its COVID-19 antibody cocktail, REGEN-COV, reduced risk of death by 20 percent in patients hospitalized with COVID-19 who had not mounted their own immune...
FDA has released draft guidance that provides recommendations to sponsors about which patient-reported outcomes (PRO) concepts to measure in cancer clinical trials.
The guidance, Core...
FDA recently approved Novo Nordisk’s Wegovy obesity drug for chronic weight management in overweight adults with at least one weigh-related condition, including high blood pressure, type 2...
FDA recently approved Amgen’s Lumakras, the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation and who have received at least...
